Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Genomic Analysis of Cardiac Surgery-Associated Mycobacterium chimaera Infections, United States.

Hasan NA, Epperson LE, Lawsin A, Rodger RR, Perkins KM, Halpin AL, Perry KA, Moulton-Meissner H, Diekema DJ, Crist MB, Perz JF, Salfinger M, Daley CL, Strong M.

Emerg Infect Dis. 2019 Mar;25(3):559-563. doi: 10.3201/eid2503.181282.

2.

Evaluation of a Novel MALDI Biotyper Algorithm to Distinguish Mycobacterium intracellulare From Mycobacterium chimaera.

Epperson LE, Timke M, Hasan NA, Godo P, Durbin D, Helstrom NK, Shi G, Kostrzewa M, Strong M, Salfinger M.

Front Microbiol. 2018 Dec 18;9:3140. doi: 10.3389/fmicb.2018.03140. eCollection 2018.

3.

Comparative evaluation of Xpert MTB/RIF assay with multiplex polymerase chain reaction for the diagnosis of tuberculous meningitis.

Sharma K, Sharma M, Chaudhary L, Modi M, Goyal M, Sharma N, Sharma A, Jain A, Dhibar DP, Jain K, Khandelwal N, Ray P, Lal V, Salfinger M.

Tuberculosis (Edinb). 2018 Dec;113:38-42. doi: 10.1016/j.tube.2018.09.002. Epub 2018 Sep 6.

PMID:
30514512
4.

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. No abstract available.

PMID:
30428263
5.

Molecular Assay Testing to Rule Out Tuberculosis-Be That Early Adopter.

Salfinger M.

JAMA Intern Med. 2018 Oct 1;178(10):1388-1389. doi: 10.1001/jamainternmed.2018.3628. No abstract available.

PMID:
30178040
6.

Mycobacterial biomaterials and resources for researchers.

Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA.

Pathog Dis. 2018 Jun 1;76(4). doi: 10.1093/femspd/fty042. Review.

7.

Implementing a Quality Management System in the Medical Microbiology Laboratory.

Carey RB, Bhattacharyya S, Kehl SC, Matukas LM, Pentella MA, Salfinger M, Schuetz AN.

Clin Microbiol Rev. 2018 May 2;31(3). pii: e00062-17. doi: 10.1128/CMR.00062-17. Print 2018 Jul. Review.

8.

Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.

Olaru ID, Albert H, Zallet J, Werner UE, Ahmed N, Rieder HL, Salfinger M, Kranzer K.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):309-320. doi: 10.5588/ijtld.17.0629.

PMID:
29471910
9.

Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson MC, Salfinger M, Somoskövi A, Warshauer DM, Wilson ML.

Clin Microbiol Rev. 2018 Jan 31;31(2). pii: e00038-17. doi: 10.1128/CMR.00038-17. Print 2018 Apr. Review.

10.

Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples.

Davidson RM, DeGroote MA, Marola JL, Buss S, Jones V, McNeil MR, Freifeld AG, Elaine Epperson L, Hasan NA, Jackson M, Iwen PC, Salfinger M, Strong M.

Int J Syst Evol Microbiol. 2017 Aug;67(8):2640-2645. doi: 10.1099/ijsem.0.001998. Epub 2017 Aug 15.

PMID:
28809146
11.

Acute disseminated mycobacteriosis in captive Atlantic guitarfish ( Rhinobatos lentiginosus).

Tuxbury KA, Young SA, Bradway DS, Marola JL, Salfinger M, Garner MM.

J Vet Diagn Invest. 2017 Nov;29(6):935-938. doi: 10.1177/1040638717721731. Epub 2017 Jul 28.

PMID:
28754065
12.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

13.

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Salfinger M, Somoskovi A.

N Engl J Med. 2016 Dec 29;375(26):2609. No abstract available.

PMID:
28032963
14.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.

PMID:
27932390
15.

Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States.

Perkins KM, Lawsin A, Hasan NA, Strong M, Halpin AL, Rodger RR, Moulton-Meissner H, Crist MB, Schwartz S, Marders J, Daley CL, Salfinger M, Perz JF.

MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1117-1118. doi: 10.15585/mmwr.mm6540a6.

16.

Novel multi-day sputum transport reagent works with routine tuberculosis tests and eliminates need for cold chain: Preliminary study of compatibility with the Xpert® MTB/RIF assay.

Kelly-Cirino CD, Curry PS, Marola JL, Helstrom NK, Salfinger M.

Diagn Microbiol Infect Dis. 2016 Nov;86(3):273-276. doi: 10.1016/j.diagmicrobio.2016.08.013. Epub 2016 Aug 16.

PMID:
27601382
17.

Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.

Singhal R, Reynolds PR, Marola JL, Epperson LE, Arora J, Sarin R, Myneedu VP, Strong M, Salfinger M.

J Clin Microbiol. 2016 Sep;54(9):2298-305. doi: 10.1128/JCM.00670-16. Epub 2016 Jun 22.

18.

Extensively drug-resistant tuberculosis in a young child after travel to India.

Salazar-Austin N, Ordonez AA, Hsu AJ, Benson JE, Mahesh M, Menachery E, Razeq JH, Salfinger M, Starke JR, Milstone AM, Parrish N, Nuermberger EL, Jain SK.

Lancet Infect Dis. 2015 Dec;15(12):1485-91. doi: 10.1016/S1473-3099(15)00356-4. Epub 2015 Nov 16. Review.

19.

Genetic diversity of clinical Mycobacterium avium subsp. hominissuis and Mycobacterium intracellulare isolates causing pulmonary diseases recovered from different geographical regions.

Ichikawa K, van Ingen J, Koh WJ, Wagner D, Salfinger M, Inagaki T, Uchiya KI, Nakagawa T, Ogawa K, Yamada K, Yagi T.

Infect Genet Evol. 2015 Dec;36:250-255. doi: 10.1016/j.meegid.2015.09.029. Epub 2015 Oct 3.

PMID:
26435330
20.

The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant Tuberculosis.

Somoskovi A, Salfinger M.

J Clin Microbiol. 2015 Dec;53(12):3715-8. doi: 10.1128/JCM.02398-15. Epub 2015 Sep 16. Review.

21.

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.

Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M.

Geneva: World Health Organization; 2008.

22.

Bedaquiline: finding the pores on the pot.

Salfinger M, Migliori GB.

Eur Respir J. 2015 Jul;46(1):289-91. doi: 10.1183/09031936.00030915. No abstract available.

23.

Bedaquiline: 10 years later, the drug susceptibility testing protocol is still pending.

Salfinger M, Migliori GB.

Eur Respir J. 2015 Feb;45(2):317-21. doi: 10.1183/09031936.00199814. No abstract available.

24.

Multidrug-resistant tuberculosis and bedaquiline.

Salfinger M, Somoskövi A.

N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235. No abstract available.

PMID:
25517715
25.

Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.

Somoskovi A, Salfinger M.

Clin Lab Med. 2014 Jun;34(2):271-95. doi: 10.1016/j.cll.2014.03.001. Review.

PMID:
24856528
26.

Molecular laboratory testing for tuberculosis: innovators, early adopters, or laggards?

Salfinger M.

Clin Infect Dis. 2014 Apr;58(7):977-9. doi: 10.1093/cid/ciu024. Epub 2014 Jan 14. No abstract available.

PMID:
24429435
27.

Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: opportunities for early diagnosis and prevention.

Mortensen E, Hellinger W, Keller C, Cowan LS, Shaw T, Hwang S, Pegues D, Ahmedov S, Salfinger M, Bower WA.

Transpl Infect Dis. 2014 Feb;16(1):67-75. doi: 10.1111/tid.12171. Epub 2014 Jan 3. Review.

PMID:
24383414
28.

It is health that is real wealth & not pieces of gold & silver.

Somoskovi A, Ahmedov S, Salfinger M.

Indian J Med Res. 2013 Mar;137(3):437-9. No abstract available.

29.

Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures.

Somoskovi A, Parsons LM, Gutierrez C, Lee E, Salfinger M.

Int J Tuberc Lung Dis. 2012 May;16(5):705-6. doi: 10.5588/ijtld.12.0078. No abstract available.

PMID:
22507939
30.

Multiple-genome comparison reveals new loci for Mycobacterium species identification.

Dai J, Chen Y, Dean S, Morris JG, Salfinger M, Johnson JA.

J Clin Microbiol. 2011 Jan;49(1):144-53. doi: 10.1128/JCM.00957-10. Epub 2010 Nov 3.

31.

Mycobacterium tuberculosis complex differentiation by genomic deletion patterns with multiplex polymerase chain reaction and melting analysis.

Pounder JI, Anderson CM, Voelkerding KV, Salfinger M, Dormandy J, Somoskovi A, Heifets L, Graham JJ, Storts DR, Petti CA.

Diagn Microbiol Infect Dis. 2010 May;67(1):101-5. doi: 10.1016/j.diagmicrobio.2009.12.014. Epub 2010 Mar 12.

PMID:
20227227
32.

Ad fontes!

Hoffner SE, Salfinger M.

Int J Tuberc Lung Dis. 2010 Mar;14(3):260. No abstract available.

PMID:
20132612
33.

Has the time come to discontinue proficiency testing?

Salfinger M, Ahmedov S.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1193. No abstract available.

PMID:
19793421
34.

"Mycobacterium canettii" isolated from a human immunodeficiency virus-positive patient: first case recognized in the United States.

Somoskovi A, Dormandy J, Mayrer AR, Carter M, Hooper N, Salfinger M.

J Clin Microbiol. 2009 Jan;47(1):255-7. doi: 10.1128/JCM.01268-08. Epub 2008 Nov 19.

35.

Coming out of the darkness.

Salfinger M, Ashkin D.

Am J Respir Crit Care Med. 2008 Apr 1;177(7):676-7. doi: 10.1164/rccm.200801-097ED. No abstract available.

PMID:
18362116
36.

Direct comparison of the genotype MTBC and genomic deletion assays in terms of ability to distinguish between members of the Mycobacterium tuberculosis complex in clinical isolates and in clinical specimens.

Somoskovi A, Dormandy J, Rivenburg J, Pedrosa M, McBride M, Salfinger M.

J Clin Microbiol. 2008 May;46(5):1854-7. doi: 10.1128/JCM.00105-07. Epub 2008 Mar 19.

37.

Mediastinal mass mimicking a tumor in a patient with bladder cancer after Bacillus Calmette-Guerin treatment.

Somoskovi A, Carlyn C, Dormandy J, Salfinger M.

Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):937-40.

PMID:
17899227
38.

DOTS implementation in a post-war, United Nations-administered territory: lessons from Kosovo.

Tigani B, Kurhasani X, Adams LV, Zhuri G, Mehmeti R, Cirillo D, Salfinger M, Dev A, Ditiu L, Migliori GB.

Respir Med. 2008 Jan;102(1):121-7. Epub 2007 Sep 18.

39.

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.

Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL.

Antimicrob Agents Chemother. 2007 Nov;51(11):3781-8. Epub 2007 Aug 27.

42.
43.

Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex?

Somoskovi A, Clobridge A, Larsen SC, Sinyavskiy O, Surucuoglu S, Parsons LM, Salfinger M.

J Clin Microbiol. 2006 Jun;44(6):2314-5. No abstract available.

44.

Universal genotyping in tuberculosis control program, New York City, 2001-2003.

Clark CM, Driver CR, Munsiff SS, Driscoll JR, Kreiswirth BN, Zhao B, Ebrahimzadeh A, Salfinger M, Piatek AS, Abdelwahab J.

Emerg Infect Dis. 2006 May;12(5):719-24.

45.

Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.

Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, Carrilho L, Diogo J, Fonseca A, Lito L, Lopes J, Pacheco T, Pessanha M, Quirim J, Sancho L, Salfinger M, Amaral L.

J Clin Microbiol. 2005 Sep;43(9):4880-4.

46.

TB and HIV in St Petersburg, Russia: a looming catastrophe?

Van Rie A, Zhemkov V, Granskaya J, Steklova L, Shpakovskaya L, Wendelboe A, Kozlov A, Ryder R, Salfinger M.

Int J Tuberc Lung Dis. 2005 Jul;9(7):740-5.

PMID:
16013768
47.

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW.

Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25.

48.

Mycobacterium africanum genotyping using novel spacer oligonucleotides in the direct repeat locus.

Brudey K, Gutierrez MC, Vincent V, Parsons LM, Salfinger M, Rastogi N, Sola C.

J Clin Microbiol. 2004 Nov;42(11):5053-7.

49.

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

Gumbo T, Louie A, Deziel MR, Parsons LM, Salfinger M, Drusano GL.

J Infect Dis. 2004 Nov 1;190(9):1642-51. Epub 2004 Sep 24. Erratum in: J Infect Dis. 2004 Dec 1;190(11):2059.

PMID:
15478070
50.

Laboratory diagnostic aspects of drug resistant tuberculosis.

Parsons LM, Somoskövi A, Urbanczik R, Salfinger M.

Front Biosci. 2004 Sep 1;9:2086-105. Review.

PMID:
15353272

Supplemental Content

Loading ...
Support Center